Late-Breaking Clinical Trials

The ACC is now accepting Late-Breaking Clinical Trial submissions for presentation at ACC.26 in New Orleans. Submit your research for a chance to be featured on cardiology's main stage and help shape the future of cardiovascular medicine by sharing your research with the global cardiovascular community.

Late-Breaking Clinical Trial submissions are accepted in the following categories:

• Major Study
• Smaller Study/Randomized Clinical Trial
• Multi-center Observational Study or Registry
• Secondary Analysis of Major Clinical Trial
• Other

Accepted Late-Breaking Clinical Trial submissions will be presented in person during one of seven LBCT sessions in the Main Tent in New Orleans and streamed live on the ACC.26 virtual platform. No video/virtual presentation option will be available.

Three LBCT sessions will be co-sponsored by the Journal of the American College of Cardiology (JACC), the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM). Each accepted submission will be considered for JACC Rapid Review and publication in JACC, JAMA and NEJM. In addition, each LBCT session will be followed by a press conference with top media outlets.